{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:12:29Z","timestamp":1790957549397,"version":"4.1.0"},"reference-count":124,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Silymarin has ameliorated obesity, type 2 diabetes (T2DM), and insulin resistance (IR) in combination with standard therapy, diet, or exercise in recent studies. Obesity and IR are the main risk factors for developing T2DM and other metabolic disorders. Today, there is a need for new strategies to target IR in patients with these metabolic diseases. In the present longitudinal study, a group of non-diabetic insulin-resistant women with type 1 and type 2 obesity were given silymarin for 12 weeks, with no change in habitual diet and physical activity. We used the Homeostatic Model Assessment for Insulin Resistance Index (HOMA-IR) to determine IR at baseline and after silymarin treatment (t = 12 weeks). We obtained five timepoint oral glucose tolerance tests, and other biochemical and clinical parameters were analyzed before and after treatment. Treatment with silymarin alone significantly reduced mean fasting plasma glucose (FPG) and HOMA-IR levels at 12 weeks compared to baseline values (p &lt; 0.05). Mean fasting plasma insulin (FPI), total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (Tg), indirect bilirubin, and C-reactive protein (CRP) levels decreased compared to baseline values, although changes were non-significant. The overall results suggest that silymarin may offer a therapeutic alternative to improve IR in non-diabetic individuals with obesity. Further clinical trials are needed in this type of patient to strengthen the results of this study.<\/jats:p>","DOI":"10.3390\/ijms25042050","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T03:36:17Z","timestamp":1707363377000},"page":"2050","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Silymarin Reduced Insulin Resistance in Non-Diabetic Women with Obesity"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4682-1704","authenticated-orcid":false,"given":"Karla","family":"MacDonald-Ramos","sequence":"first","affiliation":[{"name":"Programa de Doctorado en Ciencias Biom\u00e9dicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad de M\u00e9xico 04510, Mexico"},{"name":"Facultad de Qu\u00edmica, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad de M\u00e9xico 04510, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6221-3763","authenticated-orcid":false,"given":"Adriana","family":"Monroy","sequence":"additional","affiliation":[{"name":"Servicio de Oncolog\u00eda, Hospital General de M\u00e9xico Dr. Eduardo Liceaga, Ciudad de M\u00e9xico 06720, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Bobadilla-Bravo","sequence":"additional","affiliation":[{"name":"Facultad de Qu\u00edmica, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad de M\u00e9xico 04510, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cerb\u00f3n","sequence":"additional","affiliation":[{"name":"Facultad de Qu\u00edmica, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad de M\u00e9xico 04510, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"ref_1","unstructured":"(2021, August 27). Obesity. Available online: https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/3420."},{"key":"ref_2","unstructured":"(2021, August 27). Obesity and Overweight. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"155217","DOI":"10.1016\/j.metabol.2022.155217","article-title":"A 2022 update on the epidemiology of obesity and a call to action: As its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on","volume":"133","author":"Boutari","year":"2022","journal-title":"Metabolism"},{"key":"ref_4","unstructured":"Panuganti, K., and Nguyen, M. (2021, August 20). Obesity\u2014StatPearls\u2014NCBI Bookshelf, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459357\/."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in Obesity, Diabetes, and Related Disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and Inflammation: The Linking Mechanism and the Complications","volume":"4","author":"Ellulu","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a Link between Obesity, Metabolic Syndrome and Type 2 Diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_8","first-page":"e1570","article-title":"Maternal Adiposity Is Associated with Inflammatory Gene Expression in Leukocytes at Term Human Pregnancy: A Pilot Study","volume":"9","year":"2020","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Yung, J.H.M., and Giacca, A. (2020). Role of C-Jun N-Terminal Kinase (JNK) in Obesity and Type 2 Diabetes. Cells, 9.","DOI":"10.3390\/cells9030706"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/JOE-14-0283","article-title":"The Role of Adipose Tissue Immune Cells in Obesity and Low-Grade Inflammation","volume":"222","author":"Mraz","year":"2014","journal-title":"J. Endocrinol."},{"key":"ref_11","unstructured":"Freeman, A.M., and Pennings, N. (2019). Insulin Resistance\u2014StatPearls\u2014NCBI Bookshelf, StatPearls Publising LLC."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of Nonalcoholic Fatty Liver Disease with Insulin Resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kitade, H., Chen, G., Ni, Y., and Ota, T. (2017). Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. Nutrients, 9.","DOI":"10.3390\/nu9040387"},{"key":"ref_14","unstructured":"NIDDK (2018). Insulin Resistance & Prediabetes|NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases."},{"key":"ref_15","unstructured":"(2020, May 16). Silymarin|C25H22O10\u2014PubChem, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/1548994."},{"key":"ref_16","unstructured":"(2020, June 05). Silybum marianum (Fruit)\u2014AHPA Botanical Identity References Compendium. Available online: http:\/\/www.botanicalauthentication.org\/index.php\/Silybum_marianum_(fruit)."},{"key":"ref_17","unstructured":"(2020, June 05). Silybum marianum\u2014Wikidata. Available online: https:\/\/www.wikidata.org\/wiki\/Q193798."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5507\/bp.2005.002","article-title":"Silybin and Silymarin--New Effects and Applications","volume":"149","author":"Kren","year":"2005","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/00063030-200115070-00005","article-title":"Silymarin: A Review of Its Clinical Properties in the Management of Hepatic Disorders","volume":"15","author":"Wellington","year":"2001","journal-title":"BioDrugs"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100255","DOI":"10.1016\/j.aohep.2020.08.072","article-title":"Silymarin Is an Ally against Insulin Resistance: A Review","volume":"23","year":"2021","journal-title":"Ann. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/ptr.6153","article-title":"Silybum marianum (Milk Thistle) and Its Main Constituent, Silymarin, as a Potential Therapeutic Plant in Metabolic Syndrome: A Review","volume":"32","author":"Tajmohammadi","year":"2018","journal-title":"Phytother. Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Federico, A., Dallio, M., and Loguercio, C. (2017). Silymarin\/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules, 22.","DOI":"10.3390\/molecules22020191"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s12325-020-01251-y","article-title":"Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review","volume":"37","author":"Gillessen","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_24","unstructured":"Abenavoli, L., and Milic, N. (2017). Liver Pathophysiology, Academic Press."},{"key":"ref_25","first-page":"1","article-title":"Silymarin as a Potential Hypocholesterolaemic Drug","volume":"47","author":"Krecman","year":"1998","journal-title":"Physiol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/ptr.6171","article-title":"Milk Thistle (Silybum marianum): A Concise Overview on Its Chemistry, Pharmacological, and Nutraceutical Uses in Liver Diseases","volume":"32","author":"Abenavoli","year":"2018","journal-title":"Phytother. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ctim.2018.08.010","article-title":"The Effects of Silymarin Supplementation on Metabolic Status and Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Clinical Trials","volume":"41","author":"Hadi","year":"2018","journal-title":"Complement. Ther. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bijak, M. (2017). Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)\u2014Chemistry, Bioavailability, and Metabolism. Molecules, 22.","DOI":"10.3390\/molecules22111942"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/antiox4010204","article-title":"Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives","volume":"4","author":"Surai","year":"2015","journal-title":"Antioxidants"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.semcancer.2020.09.014","article-title":"Path of Silibinin from Diet to Medicine: A Dietary Polyphenolic Flavonoid Having Potential Anti-Cancer Therapeutic Significance","volume":"73","author":"Tuli","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.phrs.2003.12.013","article-title":"Phenolics-Rich Extracts from Silybum marianum and Prunella Vulgaris Reduce a High-Sucrose Diet Induced Oxidative Stress in Hereditary Hypertriglyceridemic Rats","volume":"50","author":"Oliyarnyk","year":"2004","journal-title":"Pharmacol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.lfs.2004.04.019","article-title":"Silymarin Induces Recovery of Pancreatic Function after Alloxan Damage in Rats","volume":"75","author":"Soto","year":"2004","journal-title":"Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Das, S., Roy, P., Pal, R., Auddy, R.G., Chakraborti, A.S., and Mukherjee, A. (2014). Engineered Silybin Nanoparticles Educe Efficient Control in Experimental Diabetes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101818"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.3390\/molecules19044654","article-title":"Silymarin Induces Expression of Pancreatic Nkx6.1 Transcription Factor and \u03b2-Cells Neogenesis in a Pancreatectomy Model","volume":"19","author":"Soto","year":"2014","journal-title":"Molecules"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.phymed.2013.09.008","article-title":"Effect of Silymarin in Pdx-1 Expression and the Proliferation of Pancreatic \u03b2-Cells in a Pancreatectomy Model","volume":"21","author":"Soto","year":"2014","journal-title":"Phytomedicine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S507","DOI":"10.33549\/physiolres.933235","article-title":"Positive Effects of Different Drug Forms of Silybin in the Treatment of Metabolic Syndrome","volume":"64","author":"Poruba","year":"2015","journal-title":"Physiol. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3109\/00498254.2015.1010633","article-title":"Improvement Bioavailability of Silymarin Ameliorates Severe Dyslipidemia Associated with Metabolic Syndrome","volume":"45","author":"Poruba","year":"2015","journal-title":"Xenobiotica"},{"key":"ref_38","first-page":"36","article-title":"Cytoprotective Effect of Silymarin against Diabetes-Induced Cardiomyocyte Apoptosis in Diabetic Rats","volume":"28","author":"Tuorkey","year":"2015","journal-title":"Biomed. Environ. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.3748\/wjg.v22.i26.6016","article-title":"Silybin Counteracts Lipid Excess and Oxidative Stress in Cultured Steatotic Hepatic Cells","volume":"22","author":"Vecchione","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1096\/fj.201700602R","article-title":"Silybin Inhibits NLRP3 Inflammasome Assembly through the NAD+\/SIRT2 Pathway in Mice with Nonalcoholic Fatty Liver Disease","volume":"32","author":"Zhang","year":"2018","journal-title":"FASEB J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.apsb.2019.02.006","article-title":"Silibinin Ameliorates Hepatic Lipid Accumulation and Oxidative Stress in Mice with Non-Alcoholic Steatohepatitis by Regulating CFLAR-JNK Pathway","volume":"9","author":"Liu","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_42","first-page":"652","article-title":"Effect of Silybin on High-Fat-Induced Fatty Liver in Rats","volume":"44","author":"Yao","year":"2011","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/pjfns-2015-0014","article-title":"Effects of Silybum marianum Extract on High-Fat Diet Induced Metabolic Disorders in Rats","volume":"66","author":"Sayin","year":"2016","journal-title":"Pol. J. Food Nutr. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1038\/s41598-019-40105-8","article-title":"Ameliorative Effect of Silybin on Bisphenol A Induced Oxidative Stress, Cell Proliferation and Steroid Hormones Oxidation in HepG2 Cell Cultures","volume":"9","author":"Lama","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40268-015-0084-x","article-title":"Efficacy of Lifestyle Changes in Subjects with Non-Alcoholic Liver Steatosis and Metabolic Syndrome May Be Improved with an Antioxidant Nutraceutical: A Controlled Clinical Study","volume":"15","author":"Sorrentino","year":"2015","journal-title":"Drugs R&D"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/2156587217696929","article-title":"Silymarin, Olibanum, and Nettle, a Mixed Herbal Formulation in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial","volume":"22","author":"Khalili","year":"2017","journal-title":"J. Evid.-Based Complement. Altern. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biopha.2017.02.016","article-title":"Safety and Efficacy of a Polyherbal Formulation for the Management of Dyslipidemia and Hyperglycemia in Patients with Advanced-Stage of Type-2 Diabetes","volume":"89","author":"Zarvandi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.phymed.2014.12.010","article-title":"Effects of Silybum marianum (L.) Gaertn. (Silymarin) Extract Supplementation on Antioxidant Status and Hs-CRP in Patients with Type 2 Diabetes Mellitus: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial","volume":"22","author":"Gargari","year":"2015","journal-title":"Phytomedicine"},{"key":"ref_49","first-page":"239","article-title":"Reassessing Bioavailability of Silymarin","volume":"16","author":"Javed","year":"2011","journal-title":"Altern. Med. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Di Costanzo, A., and Angelico, R. (2019). Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art. Molecules, 24.","DOI":"10.3390\/molecules24112155"},{"key":"ref_51","first-page":"193","article-title":"A Review of the Bioavailability and Clinical Efficacy of Milk Thistle Phytosome: A Silybin-Phosphatidylcholine Complex (Siliphos\u00ae)","volume":"10","author":"Kidd","year":"2005","journal-title":"Altern. Med. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez-S\u00e1nchez, N., Dibildox-Martinez, M., Sosa-Noguera, J., S\u00e1nchez-Medal, R., and Flores-Murrieta, F.J. (2019). Superior Silybin Bioavailability of Silybin-Phosphatidylcholine Complex in Oily-Medium Soft-Gel Capsules versus Conventional Silymarin Tablets in Healthy Volunteers. BMC Pharmacol. Toxicol., 20.","DOI":"10.1186\/s40360-018-0280-8"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1475-2840-10-62","article-title":"Effect of Silibinin on Endothelial Dysfunction and ADMA Levels in Obese Diabetic Mice","volume":"10","author":"Salomone","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1590\/1414-431X20122551","article-title":"Effect and the Probable Mechanisms of Silibinin in Regulating Insulin Resistance in the Liver of Rats with Non-Alcoholic Fatty Liver","volume":"46","author":"Yao","year":"2013","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.intimp.2013.08.019","article-title":"Silibinin Ameliorates Steatosis and Insulin Resistance during Non-Alcoholic Fatty Liver Disease Development Partly through Targeting IRS-1\/PI3K\/Akt Pathway","volume":"17","author":"Zhang","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Cheng, K.C., Asakawa, A., Li, Y.X., Chung, H.H., Amitani, H., Ueki, T., Cheng, J.T., and Inui, A. (2014). Silymarin Induces Insulin Resistance through an Increase of Phosphatase and Tensin Homolog in Wistar Rats. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084550"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/1753-0407.12083","article-title":"Beneficial Effects of Silibinin against the Progression of Metabolic Syndrome, Increased Oxidative Stress, and Liver Steatosis in Psammomys Obesus, a Relevant Animal Model of Human Obesity and Diabetes","volume":"6","author":"Bouderba","year":"2014","journal-title":"J. Diabetes"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1590\/1414-431x20144238","article-title":"Silibinin Improves Palmitate-Induced Insulin Resistance in C2C12 Myotubes by Attenuating IRS-1\/PI3K\/AKt Pathway Inhibition","volume":"48","author":"Li","year":"2015","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/10715762.2015.1116689","article-title":"Silymarin Alleviates Hepatic Oxidative Stress and Protects against Metabolic Disorders in High-Fat Diet-Fed Mice","volume":"50","author":"Feng","year":"2016","journal-title":"Free Radic. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fphar.2016.00345","article-title":"Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor","volume":"7","author":"Gu","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Alsaggar, M., Bdour, S., Ababneh, Q., El-Elimat, T., Qinna, N., and Alzoubi, K.H. (2020). Silibinin Attenuates Adipose Tissue Inflammation and Reverses Obesity and Its Complications in Diet-Induced Obesity Model in Mice. BMC Pharmacol. Toxicol., 21.","DOI":"10.1186\/s40360-020-0385-8"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0011-393X(05)80660-5","article-title":"Silymarin Reduces Hyperinsulinemia, Malondialdehyde Levels, and Daily Insulin Need in Cirrhotic Diabetic Patients","volume":"53","author":"Velussi","year":"1993","journal-title":"Curr. Ther. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0168-8278(97)80255-3","article-title":"Long-Term (12 Months) Treatment with an Anti-Oxidant Drug (Silymarin) Is Effective on Hyperinsulinemia, Exogenous Insulin Need and Malondialdehyde Levels in Cirrhotic Diabetic Patients","volume":"26","author":"Velussi","year":"1997","journal-title":"J. Hepatol."},{"key":"ref_64","first-page":"222","article-title":"Silybin-\u03b2-Cyclodextrin in the Treatment of Patients with Diabetes Mellitus and Alcoholic Liver Disease. Efficacy Study of a New Preparation of an Anti-Oxidant Agent","volume":"15","author":"Lirussi","year":"2002","journal-title":"Diabetes Nutr. Metab.-Clin. Exp."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/ptr.1988","article-title":"The Efficacy of Silybum marianum (L.) Gaertn. (Silymarin) in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial","volume":"20","author":"Huseini","year":"2006","journal-title":"Phytother. Res."},{"key":"ref_66","first-page":"213","article-title":"Pilot Study on the Additive Effects of Berberine and Oral Type 2 Diabetes Agents for Patients with Suboptimal Glycemic Control","volume":"5","author":"Villanova","year":"2012","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_67","first-page":"812","article-title":"Effect of Silymarin Supplementation on Glycemic Control, Lipid Profile and Insulin Resistance in Patients with Type 2 Diabetes Mellitus","volume":"3","author":"Elgarf","year":"2015","journal-title":"Int. J. Adv. Res."},{"key":"ref_68","first-page":"495","article-title":"Bioimpedance Analysis, Metabolic Effects and Safety of the Association Berberis Aristataisilybum Marianum: A 52-Week Double-Blind, Placebo-Controlled Study in Obese Patients with Type 2 Diabetes","volume":"31","author":"Guarino","year":"2017","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phymed.2018.03.050","article-title":"Lower Glycemic Indices and Lipid Profile among Type 2 Diabetes Mellitus Patients Who Received Novel Dose of Silybum marianum (L.) Gaertn. (Silymarin) Extract Supplement: A Triple-Blinded Randomized Controlled Clinical Trial","volume":"44","author":"Gargari","year":"2018","journal-title":"Phytomedicine"},{"key":"ref_70","first-page":"193","article-title":"Effects of a New Pharmacological Complex (Sylibin+vitamin E+phospholipids) on Some Markers of Metabolic Syndrome and of a Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease: A Preliminary Open Pilot Study","volume":"51","author":"Trappoliere","year":"2005","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/gut.2006.091967","article-title":"A New Silybin-Vitamin E-Phospholipid Complex Improves Insulin Resistance and Liver Damage in Patients with Non-Alcoholic Fatty Liver Disease: Preliminary Observations","volume":"55","author":"Federico","year":"2006","journal-title":"Gut"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1007\/s10620-006-9703-2","article-title":"The Effect of a Silybin-Vitamin E-Phospholipid Complex on Nonalcoholic Fatty Liver Disease: A Pilot Study","volume":"52","author":"Loguercio","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02836467","article-title":"The State of Insulin Resistance in Patients with Nonalcoholic Fatty Liver and the Intervention with Gankangyin","volume":"11","author":"Deng","year":"2005","journal-title":"Chin. J. Integr. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/jmv.21292","article-title":"Treatment with Silybin-Vitamin E-Phospholipid Complex in Patients with Hepatitis C Infection","volume":"80","author":"Falasca","year":"2008","journal-title":"J. Med. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.freeradbiomed.2012.02.008","article-title":"Silybin Combined with Phosphatidylcholine and Vitamin e in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial","volume":"52","author":"Loguercio","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/17474124.2015.1004312","article-title":"Effects of Mediterranean Diet Supplemented with Silybin-Vitamin E-Phospholipid Complex in Overweight Patients with Non-Alcoholic Fatty Liver Disease","volume":"9","author":"Abenavoli","year":"2015","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_77","first-page":"3118","article-title":"Effect of Silymarin plus Vitamin E in Patients with Non-Alcoholic Fatty Liver Disease. A Randomized Clinical Pilot Study","volume":"19","author":"Aller","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_78","first-page":"634","article-title":"Role of the PNPLA3 Polymorphism Rs738409 on Silymarin + Vitamin E Response in Subjects with Non-Alcoholic Fatty Liver Disease","volume":"110","author":"Aller","year":"2018","journal-title":"Rev. Esp. Enfermedades Dig."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Federico, A., Dallio, M., Gravina, A.G., Diano, N., Errico, S., Masarone, M., Romeo, M., Tuccillo, C., Stiuso, P., and Morisco, F. (2020). The Bisphenol a Induced Oxidative Stress in Non-Alcoholic Fatty Liver Disease Male Patients: A Clinical Strategy to Antagonize the Progression of the Disease. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17103369"},{"key":"ref_80","first-page":"717","article-title":"Effects of Berberis aristata\/Silybum marianum Association on Metabolic Parameters and Adipocytokines in Overweight Dyslipidemic Patients","volume":"27","author":"Derosa","year":"2013","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.phymed.2014.11.018","article-title":"Berberis aristata\/Silybum marianum Fixed Combination (Berberol\u00ae) Effects on Lipid Profile in Dyslipidemic Patients Intolerant to Statins at High Dosages: A Randomized, Placebo-Controlled, Clinical Trial","volume":"22","author":"Derosa","year":"2015","journal-title":"Phytomedicine"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2014.12.043","article-title":"Berberis aristata Combined with Silybum marianum on Lipid Profile in Patients Not Tolerating Statins at High Doses","volume":"239","author":"Derosa","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Derosa, G., D\u2019Angelo, A., Romano, D., Maffioli, P., Giuseppe, D., Angela, D., Davide, R., Pamela, M., Derosa, G., and D\u2019Angelo, A. (2017). Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlled Trial. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020343"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ptr.6282","article-title":"Metabolic Effect of Berberine\u2013Silymarin Association: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Clinical Trials","volume":"33","author":"Fogacci","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5114\/amsad\/166571","article-title":"Nutraceuticals Effect of Dietary Supplementation with a New Nutraceutical Formulation on Cardiometabolic Risk Factors: A Double-Blind, Placebo-Controlled, Randomized Clinical Study","volume":"8","author":"Cicero","year":"2023","journal-title":"Arch. Med. Sci. Atheroscler. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1089938","DOI":"10.3389\/fendo.2022.1089938","article-title":"Novel Nutraceutical Supplements with Yeast \u03b2-Glucan, Prebiotics, Minerals, and Silybum marianum (Silymarin) Ameliorate Obesity-Related Metabolic and Clinical Parameters: A Double-Blind Randomized Trial","volume":"13","author":"Santamarina","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diacare.26.4.1026","article-title":"Assessing the Shape of the Glucose Curve during an Oral Glucose Tolerance Test","volume":"26","author":"Tschritter","year":"2003","journal-title":"Diabetes Care"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2337\/dc16-0352","article-title":"The Shape of the Glucose Response Curve during an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth","volume":"39","author":"Kim","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_89","unstructured":"Secretar\u00eda de Salud (SS) (2010). Norma Oficial Mexicana Nom-015-Ssa2-2010, Para La Prevenci\u00f3n, Tratamiento y Control de La Diabetes Mellitus. D. Of. Fed., 1, 1\u201340."},{"key":"ref_90","unstructured":"(2022, September 09). Diabetes by Region\u2014IDF DIABETES ATLAS\u2014NCBI Bookshelf, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK581938\/."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2014). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 37, S81\u2013S90.","DOI":"10.2337\/dc14-S081"},{"key":"ref_92","unstructured":"World Health Organization & International Diabetes Federation (2022, January 25). Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO\/IDF Consultation. Available online: https:\/\/www.who.int\/publications\/i\/item\/definition-and-diagnosis-of-diabetes-mellitus-and-intermediate-hyperglycaemia."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"8742075","DOI":"10.1155\/2019\/8742075","article-title":"Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients","volume":"2019","author":"Federico","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1517\/14712598.2013.832751","article-title":"Berberis aristata\/Silybum marianum Fixed Combination on Lipid Profile and Insulin Secretion in Dyslipidemic Patients","volume":"13","author":"Derosa","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2337\/dc11-2476","article-title":"Glucose Response Curve and Type 2 Diabetes Risk in Latino Adolescents","volume":"35","author":"Kim","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/jdi.13227","article-title":"Shape of the Glucose Response Curve during an Oral Glucose Tolerance Test Is Associated with Insulin Clearance and Muscle Insulin Sensitivity in Healthy Non-Obese Men","volume":"11","author":"Kaga","year":"2020","journal-title":"J. Diabetes Investig."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Morris, C., O\u2019Grada, C., Ryan, M., Roche, H.M., Gibney, M.J., Gibney, E.R., and Brennan, L. (2013). Identification of Differential Responses to an Oral Glucose Tolerance Test in Healthy Adults. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072890"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Cheng, X., Yang, N., Li, Y., Sun, Q., Qiu, L., Xu, L., Ping, F., Li, W., and Zhang, H. (2019). The Shape of the Glucose Response Curve during an Oral Glucose Tolerance Test Heralds \u03b2-Cell Function in a Large Chinese Population. BMC Endocr. Disord., 19.","DOI":"10.1186\/s12902-019-0446-4"},{"key":"ref_99","unstructured":"Muniyappa, R., and Madan, R. (2000). Endotext, MDText.com, Inc."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis Model Assessment: Insulin Resistance and Beta-Cell Function from Fasting Plasma Glucose and Insulin Concentrations in Man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref_101","first-page":"3","article-title":"Norma Oficial Mexicana NOM-037-SSA2-2012, Para La Prevenci\u00f3n, Tratamiento y Control de Las Dislipidemias","volume":"24","author":"Solis","year":"2013","journal-title":"Rev. Mex. Cardiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fendo.2013.00052","article-title":"Mechanisms of Obesity-Induced Inflammation and Insulin Resistance: Insights into the Emerging Role of Nutritional Strategies","volume":"4","author":"McArdle","year":"2013","journal-title":"Front. Endocrinol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fendo.2012.00181","article-title":"Implication of Inflammatory Signaling Pathways in Obesity-Induced Insulin Resistance","volume":"3","author":"Tanti","year":"2013","journal-title":"Front. Endocrinol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fphys.2019.01607","article-title":"Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes","volume":"10","author":"Zatterale","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_105","unstructured":"Alvarez, S., Coffey, R., Algotar, A.M., and Rosolov\u00e1, H. (2022). Prediabetes, StatPearls Publishing."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3389\/fimmu.2018.01903","article-title":"The Natural Agonist of Estrogen Receptor \u03b2 Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis","volume":"9","author":"Dupuis","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"118049","DOI":"10.1016\/j.lfs.2020.118049","article-title":"Silymarin Sex-Dependently Improves Cognitive Functions and Alters TNF-\u03b1, BDNF, and Glutamate in the Hippocampus of Mice with Mild Traumatic Brain Injury","volume":"257","author":"Shokouhi","year":"2020","journal-title":"Life Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0960-0760(03)00270-X","article-title":"Silymarin Is a Selective Estrogen Receptor \u03b2 (ER\u03b2) Agonist and Has Estrogenic Effects in the Metaphysis of the Femur but No or Antiestrogenic Effects in the Uterus of Ovariectomized (Ovx) Rats","volume":"86","author":"Becker","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1002\/ptr.6789","article-title":"Evaluation of the Effect of Silybum marianum Extract on Menopausal Symptoms: A Randomized, Double-Blind Placebo-Controlled Trial","volume":"34","author":"Saberi","year":"2020","journal-title":"Phytother. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"146365","DOI":"10.1016\/j.gene.2022.146365","article-title":"Comparative Effects of Estrogen and Silibinin on Cardiovascular Risk Biomarkers in Ovariectomized Rats","volume":"823","author":"Maleki","year":"2022","journal-title":"Gene"},{"key":"ref_111","unstructured":"Congreso, E.L., Estados, G.D.E.L.O.S., Mexicanos, U., and DOF\u2014Diario Oficial de La Federaci\u00f3n NORMA Oficial Mexicana NOM-035-SSA2-2012 Para La Prevenci\u00f3n y Control de Enfermedades En La Perimenopausia y Postmenopausia de La Mujer (2022, August 15). Criterios Para Brindar Atenci\u00f3n M\u00e9dica. Available online: https:\/\/diariooficial.gob.mx\/normasOficiales.php?codp=5018&view=si#."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1210\/jc.2010-0702","article-title":"Longitudinal Study of Insulin Resistance and Sex Hormones over the Menstrual Cycle: The Biocycle Study","volume":"95","author":"Yeung","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_113","first-page":"205","article-title":"Clinical Efficacy, Safety and Tolerability of BIO-C (Micronized Silymarin) as a Galactagogue","volume":"79","author":"Callegari","year":"2008","journal-title":"Acta Biomed."},{"key":"ref_114","first-page":"109","article-title":"Insulin Resistance: Lifestyle and Nutritional Interventions","volume":"5","author":"Kelly","year":"2000","journal-title":"Altern. Med. Rev."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in Insulin Resistance: Insights into Mechanisms and Therapeutic Strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Wolosowicz, M., Prokopiuk, S., and Kaminski, T.W. (2022). Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?. Medicina, 58.","DOI":"10.3390\/medicina58040472"},{"key":"ref_117","first-page":"S50","article-title":"\u00cdndices Para La Evaluaci\u00f3n de La Resistencia a La Insulina En Individuos Mexicanos Sin Diabetes","volume":"154","year":"2018","journal-title":"Gac. M\u00e9x."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-17-0883","article-title":"METS-IR, a Novel Score to Evaluate Insulin Sensitivity, Is Predictive of Visceral Adiposity and Incident Type 2 Diabetes","volume":"178","author":"Campos","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"ref_119","first-page":"306","article-title":"Valores de Referencia de Homa-Ir y Quicki Durante El Embarazo En Mujeres Mexicanas","volume":"85","year":"2017","journal-title":"Ginecol. Obs. Mex."},{"key":"ref_120","unstructured":"(2020, May 30). NEOCHOLAL-S\u2014Medicamento\u2014PR Vademecum. Available online: https:\/\/mx.prvademecum.com\/medicamento\/neocholal-s-14928\/."},{"key":"ref_121","unstructured":"Organizaci\u00f3n Mundial de la Salud (2014). Cuestionario Mundial Sobre Actividad F\u00edsica, Departamento de enfermedades cr\u00f3nicas y promoci\u00f3n de la salud."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1123\/jpah.9.5.698","article-title":"Validity of the Global Physical Activity Questionnaire (GPAQ) in Adult Latinas","volume":"9","author":"Hoos","year":"2012","journal-title":"J. Phys. Act. Health"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Cleland, C.L., Hunter, R.F., Kee, F., Cupples, M.E., Sallis, J.F., and Tully, M.A. (2014). Validity of the Global Physical Activity Questionnaire (GPAQ) in Assessing Levels and Change in Moderate-Vigorous Physical Activity and Sedentary Behaviour. BMC Public Health, 14.","DOI":"10.1186\/1471-2458-14-1255"},{"key":"ref_124","unstructured":"Lohman, T., Roch, A., and Martorell, R. (1998). Anthropometric Standardization Reference Manual, Human Kinetic Books."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/4\/2050\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:56:51Z","timestamp":1760104611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/4\/2050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":124,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["ijms25042050"],"URL":"https:\/\/doi.org\/10.3390\/ijms25042050","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]}}}